# Growth hormone treatment in congenital tufting enteropathy: a case report and literature review

## TL;DR

A 13-year-old girl with congenital tufting enteropathy showed improved growth and motor skills after growth hormone treatment.

## Contribution

This case report explores the novel use of growth hormone therapy in a patient with congenital tufting enteropathy.

## Key findings

- GH therapy increased the patient's growth rate.
- Improvement in motor skills was observed after GH treatment.
- Potential for GH to improve quality of life in CTE patients is suggested.

## Abstract

This article aims to evaluate the effects of growth hormone (GH) therapy in a case with congenital tufting enteropathy (CTE). CTE is a rare autosomal recessive enteropathy that typically presents with persistent diarrhea. In this case, a 13-year-old girl presented with a diagnosis of CTE. Due to short stature, GH therapy was considered. Pre- and post-treatment evaluations were conducted for height, growth rate, and motor skills. As a result, an increase in growth rate and improvement in motor skills were observed with GH therapy. These findings suggest that the potential of GH therapy is to increase growth and improve the quality of life in patients with CTE. Further studies are needed to evaluate the long-term effects of GH therapy and its efficacy in broader patient groups.